LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 83 filers reported holding LEAP THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,091,673 | -24.4% | 3,210,802 | 0.0% | 0.00% | – |
Q4 2022 | $1,444,861 | -49.7% | 3,210,802 | -1.6% | 0.00% | – |
Q3 2022 | $2,872,000 | -23.3% | 3,264,171 | +0.2% | 0.00% | – |
Q2 2022 | $3,744,000 | -34.3% | 3,256,331 | 0.0% | 0.00% | – |
Q1 2022 | $5,699,000 | -43.6% | 3,256,331 | +4.4% | 0.00% | – |
Q4 2021 | $10,106,000 | -6.7% | 3,119,172 | +15.4% | 0.00% | – |
Q3 2021 | $10,837,000 | +214.3% | 2,702,625 | +28.5% | 0.00% | – |
Q2 2021 | $3,448,000 | -13.7% | 2,102,497 | -0.0% | 0.00% | – |
Q1 2021 | $3,996,000 | -6.5% | 2,102,910 | +10.7% | 0.00% | – |
Q4 2020 | $4,273,000 | +41.3% | 1,899,180 | +24.3% | 0.00% | – |
Q3 2020 | $3,025,000 | -2.1% | 1,528,055 | +3.4% | 0.00% | – |
Q2 2020 | $3,089,000 | +190.6% | 1,477,955 | +119.8% | 0.00% | – |
Q1 2020 | $1,063,000 | +41.2% | 672,515 | 0.0% | 0.00% | – |
Q4 2019 | $753,000 | -4.3% | 672,515 | 0.0% | 0.00% | – |
Q3 2019 | $787,000 | -20.8% | 672,515 | +21.1% | 0.00% | – |
Q2 2019 | $994,000 | +171.6% | 555,195 | +183.4% | 0.00% | – |
Q1 2019 | $366,000 | +32.6% | 195,875 | +41.7% | 0.00% | – |
Q4 2018 | $276,000 | -86.2% | 138,207 | -46.1% | 0.00% | – |
Q3 2018 | $1,997,000 | +6.7% | 256,268 | +23.2% | 0.00% | – |
Q2 2018 | $1,872,000 | +152.6% | 207,968 | +132.9% | 0.00% | – |
Q1 2018 | $741,000 | +210.0% | 89,291 | +133.1% | 0.00% | – |
Q4 2017 | $239,000 | +12.2% | 38,306 | +4.4% | 0.00% | – |
Q3 2017 | $213,000 | – | 36,706 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|